Prospective study assessing the effects of the novel pharmaconutraceutical Revocca (unsaponifiable compounds of avocado and soybeans in a 1:2 ratio, rosehip fruit extract, resveratrol, zinc citrate) on the clinical manifestations of osteoarthritis (VECTOR)
Objective: to evaluate the effects of the novel pharmaconutraceutical Revocca on the clinical manifestations of osteoarthritis (OA).Material and methods. A 3-month prospective study included 50 women aged 40–75 years (mean age 58.3±10.1 years) with a confirmed diagnosis of knee OA according to ACR c...
Salvato in:
| Autori principali: | , , , , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Russo |
| Pubblicazione: |
IMA-PRESS LLC
2025-12-01
|
| Serie: | Современная ревматология |
| Soggetti: | |
| Accesso online: | https://mrj.ima-press.net/mrj/article/view/1881 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|